0000927066-24-000015.txt : 20240220 0000927066-24-000015.hdr.sgml : 20240220 20240220203732 ACCESSION NUMBER: 0000927066-24-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240216 FILED AS OF DATE: 20240220 DATE AS OF CHANGE: 20240220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HEARTY JAMES O CENTRAL INDEX KEY: 0001735907 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 24656093 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 4 1 wk-form4_1708479414.xml FORM 4 X0508 4 2024-02-16 0 0000927066 DAVITA INC. DVA 0001735907 HEARTY JAMES O C/O DAVITA INC. 2000 16TH STREET DENVER CO 80202 0 1 0 0 Chief Compliance Officer 0 Common Stock 2024-02-16 4 M 0 50000 52.41 A 78448 D Common Stock 2024-02-16 4 D 0 21862 119.87 D 56586 D Common Stock 2024-02-16 4 F 0 11107 119.87 D 45479 D Common Stock 2024-02-16 4 M 0 4608 75.95 A 50087 D Common Stock 2024-02-16 4 D 0 2920 119.87 D 47167 D Common Stock 2024-02-16 4 F 0 739 119.87 D 46428 D Common Stock 2024-02-16 4 S 0 26164 119.6403 D 20264 D Stock Appreciation Rights 52.41 2024-02-16 4 M 0 50000 0 D 2022-06-20 2024-06-20 Common Stock 50000 0 D Stock Appreciation Rights 75.95 2024-02-16 4 M 0 4608 0 D 2023-03-15 2025-03-15 Common Stock 4608 4609 D Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Represents the weighted average sale price of $119.6403. The range of prices for the sale of these shares was $118.71 - $120.47 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The Stock Appreciation Rights were granted on June 20, 2019, which vested 50% each on June 20, 2022 and June 20, 2023. The Stock Appreciation Rights were granted on March 15, 2020, which 50% vested on March 15, 2023 and remaining 50% are scheduled to vest on March 15, 2024. /s/ Stephanie N. Berberich, Attorney-in-Fact 2024-02-20